Assessing Predictive and Prognostic Molecular Biomarkers in Prostate Cancer

Not Applicable

Recruiting

• Conditions: Prostate Cancer; Cancer - Prostate

• Registration Number: ACTRN12616000495426
• Lead Sponsor: Walter and Eliza Hall Institute

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-04-15
• Last Update Posted: 22 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Male
• Target Recruitment: 500

Inclusion Criteria

1.Age >18 years
2.Histological or cytological diagnosis of prostate cancer
3.Archival tumour specimen is available for molecular analysis
4.Able to be accessible for follow-up and data collection
5.Written, voluntary and informed consent for biopsy
6.Able to undergo core needle biopsy of metastases (patients must have a lesion which is deemed medically safe to biopsy)
7.Written, voluntary and informed consent for blood collection
8.Able to undergo collection of blood specimen at the beginning of each new systemic therapy

Exclusion Criteria

1.No archival tumour is specimen available for molecular analysis
2.Unable to be accessible for follow-up and data collection

Study & Design

• Study Type: Observational
• Study Design: Not specified